Abstract
With automation and globalization come a variety of issues that affect manufacturing decisions concerning standardization, certification, and regulatory validation. The biopharmaceutical industry faces challenges related to the automation process’s unseen operational costs.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have